This successful event was held for the 19th time at SCI HQ, London on Tuesday 27 April 2010. The meeting gives industrial chemists a chance to showcase their work to contemporaries and highlights new areas of research.
The event was well attended and the high quality of presentations well received, Danny Ho was awarded top honours for his talk and Dave Tapolczay CEO, MRC Technology gave the plenary lecture.
Available Conference Papers:
- Programme/Flyer
- Development of a new manufacturing route to AZD7762
Fiona Kenley, AstraZeneca PR&D - Application of high throughput reaction screening to commercial design
Steven Fussell, Pfizer R&D - The discovery of novel EP4 agonists utilising transition metal mediated cross coupling reactions and challenging fluorination methodology
Amanda Allan, GlaxoSmithKline -
Process development towards a key chiral epoxide intermediate - use of reaction monitoring in optimisation and scale-up via fragile precursors
Ed Way, AstraZeneca PR&D -
A new and mild method for preparation of aryl/het-sulfonamides from aryl/het-iodides
Danny Ho, Pfizer R&D -
The synthesis of novel, heterocyclic ACC-ase inhibitors via a claisen rearrangement reaction
John B. Taylor, Syngenta Crop Protection Research -
The selective functionalisation of pyridines and pyrimidines
Ryan Greenwood, AstraZeneca -
Rapid parallel enabling of two compounds to support a TRPV1 project
Daniel Laity, Pfizer R&D - Discovery of novel CRTh2 receptor antagonists
Maude Patoor, Novartis -
Plenary speaker: The future of drug discovery research in the UK and beyond and the potential for academic partnerships
Dave Tapolczay CEO, MRC Technology
Visit Blog